Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125276591 | 12527659 | 1 | I | 20160627 | 20160705 | 20160705 | EXP | JP-PFIZER INC-2016319170 | PFIZER | 14.00 | YR | M | Y | 0.00000 | 20160705 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125276591 | 12527659 | 1 | PS | DIFLUCAN | FLUCONAZOLE | 1 | Oral | 100 MG, DAILY | 19949 | 100 | MG | CAPSULE, HARD | |||||||
| 125276591 | 12527659 | 2 | SS | VFEND | VORICONAZOLE | 1 | Intravenous (not otherwise specified) | 21267 | POWDER FOR SOLUTION FOR INFUSION | ||||||||||
| 125276591 | 12527659 | 3 | C | CLARITHROMYCIN. | CLARITHROMYCIN | 1 | Oral | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125276591 | 12527659 | 1 | Candida infection |
| 125276591 | 12527659 | 2 | Aspergillus infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125276591 | 12527659 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125276591 | 12527659 | Haemoptysis | |
| 125276591 | 12527659 | Productive cough |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |